Posted on 12/21/17
Pfizer Giving You A Raise
Image creditPfizer (PFE) has long been a strong dividend stock. The big pharma area is littered with companies that pay nice yields. But PFE has made . . .
Posted on 12/21/17
Ortho Clinical Diagnostics Recognized as One of The Economic Times Best Asian Healthcare Brands 2017
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has been recognized as one of The Economic Times Best Asian Healthcare Brands for 2017. . . .
Posted on 12/21/17
Accenture and Roche Collaborate to Enhance Digital Healthcare for Cancer Patients
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data . . .
Posted on 12/20/17
Why 2017 Was a Year to Remember for Johnson & Johnson
With less than two weeks remaining in 2017, Johnson & Johnson (NYSE:JNJ) is on track to have its second-best year of the century so far for . . .
Posted on 12/20/17
Celgene Shareholders Excited by CAR-T News
At the recent annual American Society of Hematology (ASH) conference, Celgene (NASDAQ:CELG) reported trial results for the multiple myeloma CAR-T drug it's making with bluebird bio . . .
Posted on 12/20/17
MeiraGTx Announces Gene Therapy Manufacturing Collaboration with Oxford Genetics
MeiraGTx, a London and New York-based gene therapy company, has established a new collaboration with Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics . . .
Posted on 12/19/17
Is Cara Therapeutics, Inc. a Buy?
Small-cap biotech Cara Therapeutics (NASDAQ:CARA) is working to commercialize a drug to combat pain -- but the stock has managed to inflict a different sort of . . .
Posted on 2/19/18
Third Rock Streamlines SECURETexas Privacy and Security Certification
Helping healthcare organizations improve cybersecurity and compliance by reducing complexityThird Rock, who was awarded preferred vendor status with Texas Health Services Authority (THSA) in August this . . .
Posted on 12/18/17
Citius Announces $6 Million Registered Direct Offering
Citius Pharmaceuticals Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that it has entered into . . .
Posted on 12/18/17
Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus . . .
Posted on 12/18/17
Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000
NEW YORK--(BUSINESS WIRE)--Accelerate NY Seed Fund (ANY) and Bioharmony Therapeutics (Bioharmony) announced today an investment by ANY in Bioharmony, a New York-based company developing first-in-class antimicrobials . . .
Posted on 12/18/17
The Carlyle Group, Along with Management and Level Equity, To Acquire Net Health
Net Health, a provider of cloud-based clinical documentation, practice management, and billing solutions for specialized outpatient healthcare providers
Posted on 12/18/17
Better Buy: Johnson & Johnson vs. Merck
This big pharma claims one of the hottest cancer drugs around. But it also faces challenges for some of its biggest-selling drugs. Which big pharma is . . .
Posted on 12/18/17
The 3 Best Biotech Stocks of 2017
Biotech stocks rocked in 2017. At least a lot of them did. The SPDR S&P Biotech ETF has chalked up a gain of 40% with only . . .
Posted on 12/17/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 11, 2017 it approved non-statutory stock options to purchase an aggregate of 10,000 shares of its . . .
Posted on 12/14/17
Johnson & Johnson Presents at BMO Capital Markets Prescriptions for Success Healthcare Conference
Joanne WuenschEverybody thank you so much for joining us today. We're moving on to our second presentation, which is Johnson & Johnson. And I think Lisa . . .
Posted on 12/14/17
iMedicare and Creative Pharmacist Announce Strategic Partnership
NEW YORK--(BUSINESS WIRE)--iMedicare, the leading decision automation platform for pharmacies, and Creative Pharmacist, developer of the STRAND® Intervention Platform and the market leader in supporting clinical . . .
Posted on 12/14/17
ChartPop Chooses Candor as Exclusive Healthcare Companion
Candor, a private healthcare marketplace specializing in pairing consumers with top health plans, today announced that ChartPop has chosen Candor as their exclusive healthcare companion.Candor enables . . .
Posted on 12/12/17
IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, . . .
Posted on 12/12/17
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration
TOKYO, BASKING RIDGE, N.J. & LOS ANGELES--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Puma Biotechnology, Inc. (Nasdaq: PBYI) have announced a preclinical research collaboration . . .
Posted on 12/12/17
Buy Celgene And Regeneron On The Dips As Insiders Are Buying
According to SEC Form 4 filings between October 25 to December 4, 2017, insiders at Celgene Corp. (NASDAQ:CELG), one of the top five constituents of the . . .
Posted on 12/11/17
Mesoblast Named Global Technology Leader in Cell Therapy Industry
NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE)--Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry.Mesoblast is . . .
Posted on 12/11/17
Will Johnson & Johnson Raise Its Dividend in 2018?
Just about everyone has some products from Johnson & Johnson (NYSE:JNJ) in their medicine cabinets, ranging from over-the-counter medicines like Tylenol and Benadryl to Band-Aid bandages. . . .
Posted on 12/11/17
Cancer Genetics Prices $7 Million Registered Direct Offering
RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today . . .
Posted on 12/11/17
Nasdaq Welcomes Denali Therapeutics to The Nasdaq Stock Market
NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq:DNLI), a biopharmaceutical company focused on the discovery and development of therapies for patients with . . .

